Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

118.56 USD -5.29 (-4.27%)
Official Closing Price Updated: 7:58 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Crispr Therapeutics Ag

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
24 25 Next >
These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?
These companies just raised significant cash to advance promising drug pipelines. 
Tags Market News KROS CRSP
From Motley Fool
How Banks Have Prepared for Slowdown
One of the byproducts of the Great Recession was giving financial institutions the mindset to come prepared into situations like the present. 
Tags BAC PINS NFLX
From Motley Fool
What's The Best Biotech Stock to Buy for Treating Sickle Cell Disease?
Targeted therapies for treating sickle cell disease are finally here after a 60-year wait. 
Tags GBT CRSP Market News
From Motley Fool
2 Great Stocks You Can Buy and Hold Forever
These companies -- an online retailer and a biotech -- have plenty of growth drivers. 
Tags AMZN VRTX Market News
From Motley Fool
Have An Extra $1,000? Buy These 2 Biotech Stocks
CRISPR Therapeutics and Exelixis could be excellent long-term picks for your portfolio. 
Tags TAK EXEL VRTX
From Motley Fool
Why Adaptimmune Therapeutics, Atreca, and CRISPR Therapeutics All Tanked In March
These three clinical-stage biotechs are all bargains after last month's marketwide downturn. 
Tags Market News BCEL ADAP
From Motley Fool
Is CRISPR Therapeutics Stock a Buy?
What should investors think of this well-known gene-editing company? 
Tags NTLA EDIT SGMO
From Motley Fool
First Week of May 22nd Options Trading For CRISPR Therapeutics (CRSP)
Investors in CRISPR Therapeutics AG (CRSP) saw new options become available this week, for the May 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP... 
Tags Stocks
From Market News Video
Better Buy: Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals
One of these biotech stocks holds a monopoly in the market for drugs that treat cystic fibrosis; the other is looking to develop a treatment for COVID-19. Which one is the better buy today? 
Tags CRSP SNY REGN
From Motley Fool
First Week of May 8th Options Trading For CRISPR Therapeutics (CRSP)
Investors in CRISPR Therapeutics AG (CRSP) saw new options become available this week, for the May 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP... 
Tags Stocks
From Market News Video
Implied PTH Analyst Target Price: $117
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Coronavirus Crisis: 3 Biotech Stocks to Buy Right Now
These biotechs' profits shouldn't be dented by the COVID-19 pandemic. And their growth prospects appear to be really good. 
Tags EXEL VRTX Market News
From Motley Fool
Stocks That Hit 52-Week Lows On Monday
On Monday, 2568 stocks hit new 52-week lows. Areas of Significance: Amazon.com(NASDAQ: AMZN)is the largest company ... 
Tags JRO SHLX OPI
From Benzinga
First Week of CRSP May 1st Options Trading
Investors in CRISPR Therapeutics AG (CRSP) saw new options begin trading this week, for the May 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options... 
Tags Stocks
From Market News Video
CRISPR Therapeutics Enters Oversold Territory (CRSP)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Coronavirus Market Correction: Where to Invest $10,000 Right Now
Here are three great stocks to buy on the cheap. 
Tags TTD VRTX EPD
From Motley Fool
With the Market Down, I'm Buying These 3 Stocks
Amicus Therapeutics, Amarin, and CRISPR Therapeutics are all way oversold. 
Tags Market News AMRN CRSP
From Motley Fool
Researchers Create New CRISPR Gene-Editing System for Plants
The implications for the agricultural industry are massive. 
Tags CRSP Market News
From Motley Fool
2 Biotech Stocks to Buy as Coronavirus Fears Tank the Market
Despite fears of a COVID-19 pandemic, these two stocks are worth considering. 
Tags VRTX GBT CRSP
From Motley Fool
Hematology-Focused Biotech Imara to IPO Soon
The company has set terms for its initial public offering. 
Tags VRTX BLUE CRSP
From Motley Fool
CRSP April 24th Options Begin Trading
Investors in CRISPR Therapeutics AG (CRSP) saw new options become available today, for the April 24th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP... 
Tags Stocks
From Market News Video
Benzinga's Top Upgrades, Downgrades For March 5, 2020
Upgrades ForMonolithic Power Systems Inc(NASDAQ: MPWR), Needham upgraded the stock from Hold to Buy. In the fourth ... 
Tags CRSP top upgrades CHKP
From Benzinga
3 Biotech Stocks That Are Coronavirus Safe Havens
These stocks aren't likely to be infected with the current market worries. 
Tags GILD Market News CRSP
From Motley Fool
Is bluebird bio a Millionaire-Making Biotech?
bluebird bio presents enticing prospects, but can this biotech stock make you rich? 
Tags CRSP Market News BLUE
From Motley Fool
Can CRISPR Therapeutics Double Your Money in 2020?
This gene-editing stock has been on fire throughout 2019. Will it stay that way going forward? 
Tags VRTX EDIT SGMO
From Motley Fool
Should Investors Be Worried About Editas Medicine's Earnings Miss?
The results were worse than expected, but is it really a big deal? 
Tags Market News CRSP EDIT
From Motley Fool
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
And why it’s a potential problem for biotech investors. 
Tags BMY GBT EDIT
From Motley Fool
Better Buy: CRISPR Therapeutics vs. Intellia
These two gene-editing stocks have a lot going for them. Let's consider pipelines, partnerships, and profits to make our choice. 
Tags CRSP Market News VRTX
From Motley Fool
Better Buy: Vertex Pharmaceuticals vs. Incyte
Big drug developers reinvest revenues from cash-cow products to fuel the pipeline for the future. 
Tags CRSP LLY MPSYF
From Motley Fool
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BCLI AVEO SWAV
From Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback